Delayed therapy of experimental ischemia with competitive n-methyl-d-aspartate antagonists in rabbits

Kenneth P. Madden, Wayne Clark, Justin A. Zivin

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background and Purpose: N-methyl-D-aspartate antagonists are effective in limiting ischemic damage to the brain and spinal cord if treatment is begun at time of ischemic injury. More clinically relevant delayed therapy has not been adequately investigated. We report the temporal profile of efficacy for two competitive N-methyl-D-aspartate antagonists in therapy of central nervous system ischemia. Methods: CGS-19755 (30 mg/kg) or LY233053 (100 mg/kg) was administered 5, 30, or 60 minutes after reversible spinal cord ischemia in rabbits, induced by temporary occlusion of the infrarenal aorta. Duration of occlusion for individual animals was varied to provide a range of ischemia for each experimental group. The P50 represents the duration (in minutes) associated with a 50% probability of resultant permanent paraplegia. Neuroprotection is demonstrated if a drug prolongs the P50. Results: CGS-19755 significantly prolonged the P50 (t test, P=.003) when given 5 minutes after ischemia, but not if delayed by 30 or 60 minutes (Pso: Control, 24.1; 5 minutes, 31.4; 30 minutes, 30.1; 60 minutes, 26.6). LY233053 was efficacious at 5 (P=.0008) and 30 (P=.002) minutes, but not at 60 minutes (P50: Control, 26.8; 5 minutes, 39.4; 30 minutes, 36.0; 60 minutes, 25.6). Conclusions: These competitive N-methyl-D-aspartate antagonists are effective in limiting ischemic damage, but protection is lost if therapy is not initiated within 60 minutes of injury.

Original languageEnglish (US)
Pages (from-to)1068-1071
Number of pages4
JournalStroke
Volume24
Issue number7
StatePublished - 1993

Fingerprint

Investigational Therapies
selfotel
LY 233053
Aspartic Acid
N-Methylaspartate
Ischemia
Rabbits
Spinal Cord Ischemia
Paraplegia
Wounds and Injuries
Therapeutics
Aorta
Spinal Cord
Central Nervous System
Brain
Pharmaceutical Preparations

Keywords

  • N-methyl-D-aspartate
  • Neuronal damage
  • Rabbits
  • Spinal cord

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Clinical Neurology
  • Advanced and Specialized Nursing
  • Neuroscience(all)

Cite this

Delayed therapy of experimental ischemia with competitive n-methyl-d-aspartate antagonists in rabbits. / Madden, Kenneth P.; Clark, Wayne; Zivin, Justin A.

In: Stroke, Vol. 24, No. 7, 1993, p. 1068-1071.

Research output: Contribution to journalArticle

Madden, Kenneth P. ; Clark, Wayne ; Zivin, Justin A. / Delayed therapy of experimental ischemia with competitive n-methyl-d-aspartate antagonists in rabbits. In: Stroke. 1993 ; Vol. 24, No. 7. pp. 1068-1071.
@article{98fe666607cf4af3b349d708b63a63b1,
title = "Delayed therapy of experimental ischemia with competitive n-methyl-d-aspartate antagonists in rabbits",
abstract = "Background and Purpose: N-methyl-D-aspartate antagonists are effective in limiting ischemic damage to the brain and spinal cord if treatment is begun at time of ischemic injury. More clinically relevant delayed therapy has not been adequately investigated. We report the temporal profile of efficacy for two competitive N-methyl-D-aspartate antagonists in therapy of central nervous system ischemia. Methods: CGS-19755 (30 mg/kg) or LY233053 (100 mg/kg) was administered 5, 30, or 60 minutes after reversible spinal cord ischemia in rabbits, induced by temporary occlusion of the infrarenal aorta. Duration of occlusion for individual animals was varied to provide a range of ischemia for each experimental group. The P50 represents the duration (in minutes) associated with a 50{\%} probability of resultant permanent paraplegia. Neuroprotection is demonstrated if a drug prolongs the P50. Results: CGS-19755 significantly prolonged the P50 (t test, P=.003) when given 5 minutes after ischemia, but not if delayed by 30 or 60 minutes (Pso: Control, 24.1; 5 minutes, 31.4; 30 minutes, 30.1; 60 minutes, 26.6). LY233053 was efficacious at 5 (P=.0008) and 30 (P=.002) minutes, but not at 60 minutes (P50: Control, 26.8; 5 minutes, 39.4; 30 minutes, 36.0; 60 minutes, 25.6). Conclusions: These competitive N-methyl-D-aspartate antagonists are effective in limiting ischemic damage, but protection is lost if therapy is not initiated within 60 minutes of injury.",
keywords = "N-methyl-D-aspartate, Neuronal damage, Rabbits, Spinal cord",
author = "Madden, {Kenneth P.} and Wayne Clark and Zivin, {Justin A.}",
year = "1993",
language = "English (US)",
volume = "24",
pages = "1068--1071",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Delayed therapy of experimental ischemia with competitive n-methyl-d-aspartate antagonists in rabbits

AU - Madden, Kenneth P.

AU - Clark, Wayne

AU - Zivin, Justin A.

PY - 1993

Y1 - 1993

N2 - Background and Purpose: N-methyl-D-aspartate antagonists are effective in limiting ischemic damage to the brain and spinal cord if treatment is begun at time of ischemic injury. More clinically relevant delayed therapy has not been adequately investigated. We report the temporal profile of efficacy for two competitive N-methyl-D-aspartate antagonists in therapy of central nervous system ischemia. Methods: CGS-19755 (30 mg/kg) or LY233053 (100 mg/kg) was administered 5, 30, or 60 minutes after reversible spinal cord ischemia in rabbits, induced by temporary occlusion of the infrarenal aorta. Duration of occlusion for individual animals was varied to provide a range of ischemia for each experimental group. The P50 represents the duration (in minutes) associated with a 50% probability of resultant permanent paraplegia. Neuroprotection is demonstrated if a drug prolongs the P50. Results: CGS-19755 significantly prolonged the P50 (t test, P=.003) when given 5 minutes after ischemia, but not if delayed by 30 or 60 minutes (Pso: Control, 24.1; 5 minutes, 31.4; 30 minutes, 30.1; 60 minutes, 26.6). LY233053 was efficacious at 5 (P=.0008) and 30 (P=.002) minutes, but not at 60 minutes (P50: Control, 26.8; 5 minutes, 39.4; 30 minutes, 36.0; 60 minutes, 25.6). Conclusions: These competitive N-methyl-D-aspartate antagonists are effective in limiting ischemic damage, but protection is lost if therapy is not initiated within 60 minutes of injury.

AB - Background and Purpose: N-methyl-D-aspartate antagonists are effective in limiting ischemic damage to the brain and spinal cord if treatment is begun at time of ischemic injury. More clinically relevant delayed therapy has not been adequately investigated. We report the temporal profile of efficacy for two competitive N-methyl-D-aspartate antagonists in therapy of central nervous system ischemia. Methods: CGS-19755 (30 mg/kg) or LY233053 (100 mg/kg) was administered 5, 30, or 60 minutes after reversible spinal cord ischemia in rabbits, induced by temporary occlusion of the infrarenal aorta. Duration of occlusion for individual animals was varied to provide a range of ischemia for each experimental group. The P50 represents the duration (in minutes) associated with a 50% probability of resultant permanent paraplegia. Neuroprotection is demonstrated if a drug prolongs the P50. Results: CGS-19755 significantly prolonged the P50 (t test, P=.003) when given 5 minutes after ischemia, but not if delayed by 30 or 60 minutes (Pso: Control, 24.1; 5 minutes, 31.4; 30 minutes, 30.1; 60 minutes, 26.6). LY233053 was efficacious at 5 (P=.0008) and 30 (P=.002) minutes, but not at 60 minutes (P50: Control, 26.8; 5 minutes, 39.4; 30 minutes, 36.0; 60 minutes, 25.6). Conclusions: These competitive N-methyl-D-aspartate antagonists are effective in limiting ischemic damage, but protection is lost if therapy is not initiated within 60 minutes of injury.

KW - N-methyl-D-aspartate

KW - Neuronal damage

KW - Rabbits

KW - Spinal cord

UR - http://www.scopus.com/inward/record.url?scp=0027300760&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027300760&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 1068

EP - 1071

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 7

ER -